Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1848

2.

The radiotherapy reference panel--experiences and results of the German Hodgkin Study Group (GHSG).

Eich HT, Müller RP.

Eur J Haematol Suppl. 2005 Jul;(66):98-105.

PMID:
16007876
3.

Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma: an analysis of the German Hodgkin Study Group.

Eich HT, Engenhart-Cabillic R, Hansemann K, Lukas P, Schneeweiss A, Seegenschmiedt H, Skripnitchenko R, Staar S, Willich N, Müller RP.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1419-24. doi: 10.1016/j.ijrobp.2007.12.002. Epub 2008 Jan 30.

PMID:
18234433
4.

Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.

Eich HT, Staar S, Gossmann A, Hansemann K, Skripnitchenko R, Kocher M, Semrau R, Engert A, Josting A, Franklin J, Krug B, Diehl V, Müller RP; German Hodgkin Study Group.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1121-7.

PMID:
15001253
5.

[New therapeutic strategies for Hodgkin lymphoma in cooperation of radiation oncology and medical oncology].

Eich HT, Müller RP, Ansén S, Josting A, Engert A, Hansemann K, Pfistner B, Wolf J, Willich N, Diehl V.

Rontgenpraxis. 2003;55(3):114-24. German.

PMID:
15119314
6.

A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgkin Study Group (GHSG).

Eich HT, Gossmann A, Engert A, Kriz J, Bredenfeld H, Hansemann K, Skripnitchenko R, Brillant C, Pfistner B, Staar S, Diehl V, Müller RP; German Hodgkin Study Group.

Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1187-92. Epub 2007 Aug 20.

PMID:
17703895
7.

The HD12 panel of the German Hodgkin Lymphoma Study Group (GHSG): a quality assurance program based on a multidisciplinary panel reviewing all patients' imaging.

Eich HT, Staar S, Gossmann A, Engert A, Franklin J, Sieber M, Krug B, Diehl V, Lackner KJ, Müller RP; German Hodgkin Lymphoma Study Group.

Am J Clin Oncol. 2004 Jun;27(3):279-84.

PMID:
15170148
8.

Initiation of a teleradiotherapeutic network for patients in German lymphoma studies.

Eich HT, Müller RP, Schneeweiss A, Hansemann K, Semrau R, Willich N, Rübe C, Sehlen S, Hinkelbein M, Diehl V.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):805-8.

PMID:
14967437
9.

Quality control of involved-field radiotherapy for patients with early stage Hodgkin's lymphoma based on a central prospective review. Comparison of the results between two study generations of the German Hodgkin Study Group.

Kriz J, Bangard C, Haverkamp U, Bongartz R, Baues C, Engert A, Mueller RP, Eich HT.

Strahlenther Onkol. 2012 Aug;188(8):660-5. doi: 10.1007/s00066-012-0103-6. Epub 2012 Jun 14. Review.

PMID:
22692351
11.

[A teleradiotherapeutic network for lymphoma patients within the competence network malignant lymphomas].

Eich HT, Schneeweiss A, Skripnitchenko R, Hansemann K, Gossmann A, Müller RP.

Rontgenpraxis. 2007;56(4):145-51. Review. German.

PMID:
17390954
12.

A systematic overview of radiation therapy effects in Hodgkin's lymphoma.

Gustavsson A, Osterman B, Cavallin-Ståhl E.

Acta Oncol. 2003;42(5-6):589-604. Review.

PMID:
14596517
13.

Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group.

Eich HT, Haverkamp U, Engert A, Kocher M, Skripnitchenko R, Brillant C, Sehlen S, Dühmke E, Diehl V, Müller RP.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):860-5. Epub 2005 May 31.

PMID:
15925455
14.

Evolution of radiation therapy within the German Hodgkin Study Group trials.

Eich HT, Kriz J, Müller RP.

J Natl Compr Canc Netw. 2011 Sep 1;9(9):1073-80. Review.

PMID:
21917628
15.

Treatment of Hodgkin's disease: results and current concepts of the German Hodgkin's Lymphoma Study Group.

Sieber M, Engert A, Diehl V.

Ann Oncol. 2000;11 Suppl 1:81-5. Review.

PMID:
10707785
17.

Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.

Engert A, Franklin J, Eich HT, Brillant C, Sehlen S, Cartoni C, Herrmann R, Pfreundschuh M, Sieber M, Tesch H, Franke A, Koch P, de Wit M, Paulus U, Hasenclever D, Loeffler M, Müller RP, Müller-Hermelink HK, Dühmke E, Diehl V.

J Clin Oncol. 2007 Aug 10;25(23):3495-502. Epub 2007 Jul 2.

18.

Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: a systematic review.

Bekelman JE, Yahalom J.

Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):492-8. doi: 10.1016/j.ijrobp.2008.04.058. Epub 2008 Sep 17. Review.

PMID:
18804334
19.

The optimal dose of radiation in Hodgkin's disease: an analysis of clinical and treatment factors affecting in-field disease control.

Mendenhall NP, Rodrigue LL, Moore-Higgs GJ, Marcus RB Jr, Million RR.

Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):551-61.

PMID:
10348284
20.

Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.

Sieniawski M, Franklin J, Nogova L, Glossmann JP, Schober T, Nisters-Backes H, Diehl V, Josting A.

J Clin Oncol. 2007 May 20;25(15):2000-5. Epub 2007 Apr 9.

Items per page

Supplemental Content

Write to the Help Desk